Portfolio Holdings Detail for ISIN IE000X08RX14
| Stock Name / Fund | iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | EDMNZx(NZD) CXE |
Holdings detail for BMY
| Stock Name | Bloomsbury Publishing Plc |
| Ticker | BMY(GBX) LSE |
| TYPE | Common Stock |
| Country | UK |
| ISIN | GB0033147751 |
| LEI | 213800ZL2PEC4C6UOQ53 |
Show aggregate BMY holdings
News associated with BMY
- BMY Crosses Above Average Analyst Target
- In recent trading, shares of Bristol Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $59.90, changing hands for $60.18/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade - 2025-03-07 11:59:23
- Is Bristol-Myers Stock Outperforming the Dow?
- As Bristol-Myers has outperformed the Dow recently, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. - 2025-03-06 18:56:07
- Is Bristol-Myers Stock Outperforming the Dow?
- As Bristol-Myers has outperformed the Dow recently, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. - 2025-03-06 16:25:21
- Is Merck Stock Underperforming the S&P 500?
- Despite Merck’s recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects. - 2025-02-28 15:01:26
- Is Merck Stock Underperforming the S&P 500?
- Despite Merck’s recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects. - 2025-02-28 14:55:47
- Is Merck Stock Underperforming the S&P 500?
- Despite Merck’s recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects. - 2025-02-28 12:54:31
- Bristol-Myers Squibb Sees Unusually High Options Volume (NYSE:BMY)
- Bristol-Myers Squibb (NYSE:BMY – Get Free Report) saw some unusual options trading on Tuesday. Traders acquired 46,473 call options on the company. This represents an increase of approximately 61% compared to the typical daily volume of 28,883 call options. Insider Activity In other news, EVP Samit Hirawat bought 1,823 shares of Bristol-Myers Squibb stock in […] - 2025-02-27 06:28:50
- iShares MSCI USA Value Factor ETF Experiences Big Inflow
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI USA Value Factor ETF (Symbol: VLUE) where we have detected an approximate $209.8 million dollar inflow -- that's a 2.8% increase week ov - 2025-02-21 16:21:45
- Nations Financial Group Inc. IA ADV Sells 708 Shares of Bristol-Myers Squibb (NYSE:BMY)
- Nations Financial Group Inc. IA ADV lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 10.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,150 shares of the biopharmaceutical company’s stock after selling 708 shares during the […] - 2025-02-19 09:19:44
- BMY : New Five-Year Sotyktu Data Show Durable, Safe Response In Moderate-to-Severe Plaque Psoriasis
- (RTTNews) - Bristol Myers Squibb (BMY) announced new five-year results from the POETYK PSO long-term extension trial of Sotyktu (deucravacitinib) treatment in adult patients with moderate-to-severe plaque psoriasis. The safety profile of Sotyktu remained consistent through five y - 2025-02-17 06:32:55
- Fund Update: AMERIPRISE FINANCIAL INC Just Disclosed New Holdings
- AMERIPRISE FINANCIAL INC just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-14 17:18:28
- Fund Update: M&G Plc Just Disclosed New Holdings
- M&G Plc just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-11 17:23:36
- Wells Fargo & Company Increases Bristol-Myers Squibb (NYSE:BMY) Price Target to $62.00
- Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price increased by Wells Fargo & Company from $60.00 to $62.00 in a report published on Friday morning,Benzinga reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. Several other analysts also recently commented on BMY. Daiwa Capital Markets raised Bristol-Myers Squibb from […] - 2025-02-10 16:58:46
- Fund Update: SATURNA CAPITAL CORP Just Disclosed New Holdings
- SATURNA CAPITAL CORP just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-07 22:29:23
- Stocks Settle Mainly Higher Ahead of Friday’s US Payroll Report
- The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.36%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.54%. March E-mini S&P futures (ESH25 ) rose by +0.20%, and March E-mini Nasdaq futures... - 2025-02-07 14:27:59
- Stocks Settle Mainly Higher Ahead of Friday’s US Payroll Report
- The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.36%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.54%. March E-mini S&P futures (ESH25 ) rose by +0.20%, and March E-mini Nasdaq futures... - 2025-02-07 12:32:03
- Stocks Settle Mainly Higher Ahead of Friday’s US Payroll Report
- The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.36%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.54%. March E-mini S&P futures (ESH25 ) rose by +0.20%, and March E-mini Nasdaq futures... - 2025-02-07 10:59:20
- Stocks Settle Mainly Higher Ahead of Friday’s US Payroll Report
- The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.36%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.54%. March E-mini S&P futures (ESH25 ) rose by +0.20%, and March E-mini Nasdaq futures... - 2025-02-07 03:49:53
- Stocks See Support from Positive Earnings Results
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.10%. March E-mini S&P futures (ESH25 ) are up by +0.07%, and March E-mini Nasdaq... - 2025-02-07 00:32:18
- Stocks Find Support From Strong Earnings Results
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.29%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.18%. March E-mini S&P futures (ESH25 ) are up by +0.21%, and March E-mini Nasdaq... - 2025-02-06 23:06:07
- Stocks See Support from Positive Earnings Results
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.10%. March E-mini S&P futures (ESH25 ) are up by +0.07%, and March E-mini Nasdaq... - 2025-02-06 18:40:45
- Stocks See Support from Positive Earnings Results
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.10%. March E-mini S&P futures (ESH25 ) are up by +0.07%, and March E-mini Nasdaq... - 2025-02-06 18:29:28
- Stocks Find Support From Strong Earnings Results
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.29%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.18%. March E-mini S&P futures (ESH25 ) are up by +0.21%, and March E-mini Nasdaq... - 2025-02-06 18:29:26
- Stocks Find Support From Strong Earnings Results
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.29%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.18%. March E-mini S&P futures (ESH25 ) are up by +0.21%, and March E-mini Nasdaq... - 2025-02-06 16:45:16
- Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Spire Wealth Management
- Spire Wealth Management raised its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 18,338 shares of the biopharmaceutical company’s stock after purchasing an additional 760 shares during the quarter. Spire Wealth Management’s holdings in Bristol-Myers Squibb were worth $1,037,000 at the end […] - 2025-02-05 08:54:56
- SPHD, KMI, BMY, T: Large Inflows Detected at ETF
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 High Dividend Low Volatility ETF (Symbol: SPHD) where we have detected an approximate $782.9 million dollar inflow -- that's a 23 - 2025-02-04 16:05:03
- R Squared Ltd Makes New Investment in Bristol-Myers Squibb (NYSE:BMY)
- R Squared Ltd purchased a new position in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 710 shares of the biopharmaceutical company’s stock, valued at approximately $40,000. Several other hedge funds have also added to […] - 2025-02-03 08:47:10
- What Are Wall Street Analysts' Target Price for Bristol-Myers Squibb Stock?
- Pharma giant Bristol-Myers Squibb has notably outpaced the broader pharma industry over the past year and analysts remain moderately bullish on the stock’s prospects. - 2025-01-31 12:34:40
- What Are Wall Street Analysts' Target Price for Bristol-Myers Squibb Stock?
- Pharma giant Bristol-Myers Squibb has notably outpaced the broader pharma industry over the past year and analysts remain moderately bullish on the stock’s prospects. - 2025-01-31 10:29:40
- Bristol-Myers Squibb (NYSE:BMY) Price Target Raised to $65.00
- Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price boosted by Citigroup from $60.00 to $65.00 in a report published on Tuesday,Benzinga reports. They currently have a neutral rating on the biopharmaceutical company’s stock. Several other brokerages also recently issued reports on BMY. Truist Financial increased their price target on Bristol-Myers Squibb from $62.00 […] - 2025-01-31 08:58:54
iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc) BMY holdings
| Date | Number of BMY Shares Held | Base Market Value of BMY Shares | Local Market Value of BMY Shares | Change in BMY Shares Held | Change in BMY Base Value | Current Price per BMY Share Held | Previous Price per BMY Share Held |
|---|
| 2024-11-08 (Friday) | 191,941 | USD 10,391,686 | USD 10,391,686 | 0 | USD -109,406 | USD 54.14 | USD 54.71 |
| 2024-11-07 (Thursday) | 191,941 | USD 10,501,092 | USD 10,501,092 | 0 | USD -109,406 | USD 54.71 | USD 55.28 |
| 2024-11-06 (Wednesday) | 191,941 | USD 10,610,498 | USD 10,610,498 | 0 | USD -128,601 | USD 55.28 | USD 55.95 |
| 2024-11-05 (Tuesday) | 191,941 | USD 10,739,099 | USD 10,739,099 | 0 | USD 95,971 | USD 55.95 | USD 55.45 |
| 2024-11-04 (Monday) | 191,941 | USD 10,643,128 | USD 10,643,128 | 0 | USD 216,893 | USD 55.45 | USD 54.32 |
| 2024-11-01 (Friday) | 191,941 | USD 10,426,235 | USD 10,426,235 | -2,952 | USD -442,948 | USD 54.32 | USD 55.77 |
| 2024-10-31 (Thursday) | 194,893 | USD 10,869,183 | USD 10,869,183 | 0 | USD 606,118 | USD 55.77 | USD 52.66 |
| 2024-10-30 (Wednesday) | 194,893 | USD 10,263,065 | USD 10,263,065 | 0 | USD 31,182 | USD 52.66 | USD 52.5 |
| 2024-10-29 (Tuesday) | 194,893 | USD 10,231,883 | USD 10,231,883 | 0 | USD -27,285 | USD 52.5 | USD 52.64 |
| 2024-10-28 (Monday) | 194,893 | USD 10,259,168 | USD 10,259,168 | 0 | USD 140,323 | USD 52.64 | USD 51.92 |
| 2024-10-25 (Friday) | 194,893 | USD 10,118,845 | USD 10,118,845 | 0 | USD -194,893 | USD 51.92 | USD 52.92 |
| 2024-10-24 (Thursday) | 194,893 | USD 10,313,738 | USD 10,313,738 | 0 | USD -27,285 | USD 52.92 | USD 53.06 |
| 2024-10-23 (Wednesday) | 194,893 | USD 10,341,023 | USD 10,341,023 | 0 | USD 58,468 | USD 53.06 | USD 52.76 |
| 2024-10-22 (Tuesday) | 194,893 | USD 10,282,555 | USD 10,282,555 | 0 | USD 124,732 | USD 52.76 | USD 52.12 |
| 2024-10-21 (Monday) | 194,893 | USD 10,157,823 | USD 10,157,823 | 0 | USD -214,382 | USD 52.12 | USD 53.22 |
| 2024-10-18 (Friday) | 194,893 | USD 10,372,205 | USD 10,372,205 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of BMY by Blackrock for IE000X08RX14
Show aggregate share trades of BMY| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2024-11-01 | SELL | -2,952 | | | 54.320* | | 52.93 Profit of 156,243 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of BMY
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-03-12 | 1,530,334 | 10,459 | 3,326,729 | 46.0% |
| 2025-03-11 | 2,886,923 | 5,907 | 5,509,191 | 52.4% |
| 2025-03-10 | 3,843,864 | 23,076 | 7,842,520 | 49.0% |
| 2025-03-07 | 3,817,777 | 11,178 | 7,568,538 | 50.4% |
| 2025-03-06 | 1,747,151 | 5,506 | 3,698,122 | 47.2% |
| 2025-03-05 | 2,363,049 | 3,360 | 3,502,066 | 67.5% |
| 2025-03-04 | 2,980,720 | 18,161 | 5,909,825 | 50.4% |
| 2025-03-03 | 1,949,381 | 15,895 | 3,747,817 | 52.0% |
| 2025-02-28 | 2,681,638 | 11,372 | 4,177,361 | 64.2% |
| 2025-02-27 | 1,755,683 | 9,246 | 3,325,135 | 52.8% |
| 2025-02-26 | 1,431,385 | 2,042 | 2,832,566 | 50.5% |
| 2025-02-25 | 2,620,875 | 7,601 | 5,941,640 | 44.1% |
| 2025-02-24 | 2,236,755 | 21,085 | 5,186,009 | 43.1% |
| 2025-02-21 | 1,253,126 | 7,101 | 3,783,624 | 33.1% |
| 2025-02-20 | 1,154,507 | 4,639 | 3,227,165 | 35.8% |
| 2025-02-19 | 1,677,957 | 7,704 | 4,657,057 | 36.0% |
| 2025-02-18 | 1,849,561 | 10,688 | 4,704,665 | 39.3% |
| 2025-02-14 | 1,931,800 | 87,809 | 4,410,440 | 43.8% |
| 2025-02-13 | 1,664,787 | 5,723 | 3,827,872 | 43.5% |
| 2025-02-12 | 1,470,924 | 14,752 | 3,653,059 | 40.3% |
| 2025-02-11 | 1,609,862 | 29,897 | 3,139,818 | 51.3% |
| 2025-02-10 | 3,477,899 | 1,274 | 7,276,347 | 47.8% |
| 2025-02-07 | 2,321,402 | 5,147 | 4,873,774 | 47.6% |
| 2025-02-06 | 5,170,734 | 37,945 | 11,436,217 | 45.2% |
| 2025-02-05 | 1,641,498 | 3,210 | 5,188,100 | 31.6% |
| 2025-02-04 | 2,509,193 | 2,454 | 5,101,941 | 49.2% |
| 2025-02-03 | 2,443,311 | 2,122 | 5,119,102 | 47.7% |
| 2025-01-31 | 981,746 | 4,152 | 2,446,744 | 40.1% |
| 2025-01-30 | 1,252,295 | 118 | 3,201,420 | 39.1% |
| 2025-01-29 | 959,883 | 1,403 | 2,640,262 | 36.4% |
| 2025-01-28 | 1,521,558 | 8,640 | 3,382,807 | 45.0% |
| 2025-01-27 | 1,517,826 | 6,308 | 3,616,309 | 42.0% |
| 2025-01-24 | 2,370,142 | 1,717 | 4,507,753 | 52.6% |
| 2025-01-23 | 2,973,247 | 18,234 | 6,130,799 | 48.5% |
| 2025-01-22 | 1,439,822 | 35,941 | 2,808,873 | 51.3% |
| 2025-01-21 | 1,626,477 | 290,081 | 3,509,763 | 46.3% |
| 2025-01-17 | 2,380,342 | 224,406 | 4,773,303 | 49.9% |
| 2025-01-16 | 1,202,569 | 1,178 | 3,981,337 | 30.2% |
| 2025-01-15 | 818,488 | 3,165 | 3,104,182 | 26.4% |
| 2025-01-14 | 1,099,655 | 2,347 | 2,485,519 | 44.2% |
| 2025-01-13 | 1,302,437 | 2,319 | 2,738,566 | 47.6% |
| 2025-01-10 | 1,250,630 | 15,213 | 3,455,397 | 36.2% |
| 2025-01-08 | 2,355,401 | 1,504 | 5,303,645 | 44.4% |
| 2025-01-07 | 1,255,198 | 2,539 | 3,812,352 | 32.9% |
| 2025-01-06 | 1,303,559 | 15,271 | 3,107,699 | 41.9% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.